May 31-June 4, 2019 Chicago, IL Details: Exhibition booth #19135 Satellite symposium: New Era of Biomarker-driven Clinical Trials and Regulatory Approvals in US and China |June 1, 2019 Poster Presentations: Plasma cell free DNA (cfDNA) based somatic aberrations detected in treatment naïve metastatic hormone sensitive prostate cancer (mHSPC), hormonally ablated mHSPC and metastatic castration resistant...